Bone Marrow Morphologic Findings in Patients Receiving IDH Inhibitor Therapy in Combination with Intensive Induction Chemotherapy: Challenges with Interpretation of the Day 14 Bone Marrow Biopsy
Year: 2019
Type: conference-abstract
Source: Blood
Institutions: Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Brigham and Women's Hospital, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, Vanderbilt University, Celgene (United States), Agios Pharmaceuticals (United States), Dana-Farber Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2986958428
